This article is more than 5 years old. Information may no longer be current.
Kidney transplant patients with PKD may have a reduced risk of cancer compared to patients without PKD
Click Here to Manage Email Alerts
Patients with polycystic kidney disease may have a reduced risk of cancer compared with patients with other kidney diseases, according to a study appearing in the Journal of the American Society of Nephrology (JASN).
James B. Wetmore, MD, MS, from the University of Kansas Medical Center, and his colleagues conducted the first study to examine cancer risk in kidney transplant recipients with PKD and to compare their risk to that of other kidney transplant recipients.
Read also: Study finds kidney transplant offers longer survival compared to intensive dialysis
The team analyzed data from the National Cancer Institute's Transplant Cancer Match Study, which contains information on all solid organ transplant recipients in the United States, as well as data from 15 population-based U.S. cancer registries. For PKD recipients, the investigators compared overall cancer risk to that in the general population. They also compared cancer incidence in PKD vs non-PKD kidney transplant recipients. The analysis included 10,166 kidney transplant recipients with PKD and 107,339 without.
After adjusting for demographic differences between kidney recipients with PKD and other recipients, PKD patients were 16% less likely to develop cancer than others who received a kidney transplant. Compared with the general population, overall cancer risk was increased 48% in PKD recipients, while the overall cancer risk in non-PKD recipients was increased 86%.
“The reason for the decreased risk is uncertain, but some factor or factors in PKD patients—either inherent in the disease process itself or related to the care PKD patients receive—is associated with lower risks of cancers,” said Wetmore. “Further study is required to determine how PKD might influence the development of cancer.”
Wetmore speculated that PKD may induce certain anti-neoplastic defense mechanisms that guard against the subsequent development of cancer. Alternatively, it may be that PKD patients, who are frequently aware that they have a progressive medical condition and who therefore typically receive close medical care for many years or decades, engage in other healthy behaviors that prevent cancer.
The article, entitled “Polycystic Kidney Disease and Cancer after Renal Transplantation,” appears online at http://jasn.asnjournals.org/